TYDELAZ, created in 2014 (United States), from 3 sister brands and 2214 competing brands. The TYDELAZ brand is owned by SYNDAX PHARMACEUTI COM USD0.0001, a company listed in New York. TYDELAZ belongs to the Biotechnology business sector.

TYDELAZ is a brand of SYNDAX PHARMACEUTI COM USD0.0001 (SNDX) Share price

International deposit : 2014 Business sector Biotechnology

Share price and profitability of the share SYNDAX PHARMACEUTI COM USD0.0001 (TYDELAZ)

Buy SYNDAX PHARMACEUTI COM USD0.0001 share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 20.75

Portfolio valuation
SYNDAX PHARMACEUTI COM USD0.0001 (TYDELAZ) over 5 years* USD 65.70

Stock market history SYNDAX PHARMACEUTI COM USD0.0001 (TYDELAZ)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
SYNDAX PHARMACEUTI COM USD0.0001

SYNDAX PHARMACEUTI COM USD0.0001
SYNDAX PHARMACEUTI COM USD0.0001
See more brands of SYNDAX PHARMACEUTI COM USD0.0001

Rival brands
TYDELAZ

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS